Delivery Order SPE2DB22D1017-SPE2DB25FG6DD
- Not listed
- The Defense Logistics Agency awarded a $9,188.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a non-set-aside, competitively awarded contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,804.29 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded on July 24, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $17,249.94 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,288.59 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection). This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 29, 2025, issued on April 28, 2025. AmerisourceBergen will perform and deliver from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections valued at $17,159.56. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was made on a non-set-aside,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,575.97 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections (2.24 mL units). This firm fixed-price contract, awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, was competitively awarded with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a FDA-approved medication used to treat...
- The Defense Logistics Agency awarded a $7,807.46 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $8,579.78 on May 6, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by May 7, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,601.43 for Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in osteoporosis treatment. This firm fixed-price delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured with no...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6DDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,859.39 to AmerisourceBergen Drug Corp for the supply of Forteo (560 micrograms/2.24 milliliters) pen injections. This non-competitive, firm fixed-price delivery order was issued on June 30, 2025, with an ultimate completion date of July 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA contract vehicle enables the supply of an extensive portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Forteo, a medication used in bone health management, reflects the company's ongoing role as a primary vendor supporting Defense Health Agency and other federal healthcare systems through a flexible and comprehensive pharmaceutical supply mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 6/30/25 |